Kirsten AM; Förster K; Radeczky E; Linnhoff A; Bálint Beatrix; Watz H; Wray H; Salkeld L; Cullberg M; Larsson B:
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD.
PULMONARY PHARMACOLOGY & THERAPEUTICS, 31.
pp. 36-41.
ISSN 1094-5539
(2015)